KOSDAQ · Healthcare · ₩198B
₩3,2200.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 6.6% · as of 26.09.11
Among 34 바이오 peers
Quarterly Revenue Growth
“해외 판매 확대가 다음 성장의 중심축으로 떠올랐어요.”
In the company's words · 2026 2분기 filing